| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Pazopanib | FIMM | pan-cancer | AAC | 0.051 | 0.8 |
| mRNA | cediranib | CTRPv2 | pan-cancer | AAC | 0.015 | 0.8 |
| mRNA | lenalidomide | FIMM | pan-cancer | AAC | -0.045 | 0.8 |
| mRNA | Imatinib | GDSC1000 | pan-cancer | AAC | 0.014 | 0.8 |
| mRNA | GW843682X | GDSC1000 | pan-cancer | AAC | -0.014 | 0.8 |
| mRNA | GNF-2 | GDSC1000 | pan-cancer | AAC | -0.014 | 0.8 |
| mRNA | MLN4924 | GDSC1000 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | pluripotin | CTRPv2 | pan-cancer | AAC | -0.0094 | 0.8 |
| mRNA | BMS-345541 | GDSC1000 | pan-cancer | AAC | -0.0082 | 0.8 |
| mRNA | GSK-650394 | GDSC1000 | pan-cancer | AAC | 0.0089 | 0.8 |